Top 5 This Week

Related Posts

Doctors suggest Ozempic for seniors aged 65 and above to prevent diseases related to obesity.

- Advertisement -

“New Study Shows Benefits of GLP-1 Drugs like Ozempic for Older Adults”

A recent study from KFF Health has revealed that only 9% of older adults aged 65 and up have taken GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, with just 1% using them specifically for weight-loss purposes. However, some doctors are now recommending that more seniors consider incorporating these medications into their health regimen for improved longevity.

Dr. Jennie Stanford, an obesity medicine physician, highlighted the importance of addressing medical problems that often arise as we age, such as diabetes, cardiovascular disease, metabolic syndrome, cancers, and dementia. GLP-1 receptor agonists like Ozempic have been shown to not only treat diabetes and reduce cardiovascular disease risk but also potentially lower the risks of dementia and obesity-associated cancers.

Dr. Brett Osborn, a neurosurgeon and longevity doctor, emphasized the significance of managing obesity in older adults, referring to it as a “gateway disease” that can lead to various serious health conditions. Weight loss through medications like Ozempic can not only promote mobility and balance but also reduce the risk of falls, which are a major concern for seniors.

Despite the clear benefits, some barriers exist for seniors to access these medications, primarily due to cost and insurance coverage limitations. Additionally, older adults may be at a higher risk of adverse effects from GLP-1 drugs, such as kidney dysfunction and medication interactions.

Overall, experts recommend a holistic approach to weight loss for seniors, combining GLP-1 medications with lifestyle changes like exercise and a balanced diet. While there are risks involved, the potential benefits of these drugs are believed to outweigh them, with companies like Novo Nordisk advocating for broader coverage and access for seniors living with obesity.

In conclusion, the study underscores the potential benefits of GLP-1 drugs like Ozempic for older adults and the importance of addressing obesity as a key risk factor for age-related diseases. By working closely with healthcare professionals and adopting a comprehensive approach to weight management, seniors can improve their overall health and quality of life.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles